A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence-based analyses of individual agents commonly used in the treatment of ...

Insomnia is a significant health and quality of life concern for older adults, with up to half of all adults over the age of 65 experiencing insomnia symptoms. In a new study, researchers in the Penn ...

This Nature Outlook is editorially independent, produced with financial support from Avadel. Miranda cannot remember a time in her life when she did not have insomnia. The 23 year old, who asked for ...

The Food and Drug Administration has recommended that the bedtime dose of the insomnia drug zolpidem be lowered because there's new evidence that, after taking the current dose, the level of drug ...

TOKYO, May 28, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) has been approved in ...

WASHINGTON — The first generic versions of the insomnia drug Ambien won federal approval Monday. The Food and Drug Administration said it approved versions of the immediate-release tablets made by 13 ...

As far back as the 1800s, patients were prescribed medication for insomnia. While barbiturates were popularized in the early 1900s, they were soon replaced by benzodiazepines, such as Valium (1960s ...

The U.S. Food and Drug Administration approved Belsomra (suvorexant) tablets for use as needed to treat insomnia. Belsomra is an orexin receptor antagonist and is the first approved drug of this type.

The "Insomnia: Opportunity Assessment and Forecast Update" report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM and provides an Excel-based forecast model for the ...

Health Canada Approves Slenyto® - Extended-Release Melatonin Formulation - as a Prescription Drug for Insomnia in Children with Autism Spectrum disorder and Smith Magenis Syndrome ...

Thirty-four experts and a literature supervisor got together in order to reach a consensus regarding the definition, diagnosis and pharmacological treatment of insomnia. Insomnia is a subjective ...